-
Pine Labs
205.00 283.70(%) -
HDFC Bank
738.70 682.00(%) -
Meesho
244.80 254.65(%) -
Glass Wall Syst.
318.00 318.00(%) -
Cholaman.Inv.&Fn
1,756.50 1,299.80(%) -
Solar Industries
20,243.65 22,630.05(%) -
Cupid
265.35 298.95(%) -
Aster DM Quality
746.55 519.80(%) -
Protean eGov
656.45 940.00(%) -
Gabriel India
1,495.35 1,600.00(%) -
Nippon ETF Liq.
999.99 978.01(%) -
Transrail Light
487.90 800.35(%) -
Reliance Industries
1,237.80 1,232.35(%) -
JSW Dulux
3,131.20 2,649.05(%) -
Kaynes Tech
3,427.35 2,995.85(%) -
Apar Inds.
17,916.55 6,800.00(%) -
Titan Company
4,983.70 5,187.45(%) -
Dixon Technolog.
12,997.00 9,605.05(%) -
Eternal
341.80 368.40(%) -
Larsen & Toubro
3,867.50 3,288.65(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Zydus Lifesciences Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
- Zydus Group
- BSE Code : 20883.0
- ISIN : INE010B01027
-
Today’s Low
1,160.00 -
Today’s High
1,178.00
-
Open
1,161.00 -
Perv Close
1,161.00 -
52W Low
835.50 -
52W High
1,205.00
Key Indicators
-
P/E(TTM)
31.77
-
Mar.Cap (₹Cr.)
115,939.87
-
Div & Yield %
0.09
-
Book Value(₹)
237.30
-
Debt-Equity Ratio
0.11
-
AGM Date
22-Sep-2026
-
EPS
36.54
-
P/E Ratio
31.77
Financials Ratios
-
Debt-Equity Ratio
0.05
-
Mar.Cap (₹Cr.)
115,939.87
-
RONW (%)
20.64
-
ROCE (%)
23.94
Score Board
-
Equity (₹ in Cr.)
99.75
-
BV (₹)
237.30
-
Sales( ₹ in Cr.)
11,486.40
-
NP (in Cr.)
3,691.18
-
NP Var(%)
-36.0
-
Div%
100.0
-
CPS (₹)
42.60
-
EPS (₹)
37.00
-
Traded Value (₹ in Lakhs)
115,810.19
-
52 Week High
1,205.00
-
52 Week Low
835.50
-
Price BSE
1161.0
-
Price NSE
1,162.00
-
Market Capital( in Cr.)
115,810.19
-
P/C Ratio
27.20
-
P/E Ratio
31.40
-
Price Vs.BV
37.00
-
22-Sep-2026( 01:00)
Hot Pursuit - Zydus... - <p>Zydus Lifesciences Ltd gain...
-
18-Sep-2026( 01:05)
Hot Pursuit - Zydus... - <p>Zydus Lifesciences Ltd rose...
-
11-Sep-2026( 03:33)
Hot Pursuit - Zydus... - <p>Zydus Lifesciences Ltd anno...
-
27-Aug-2026( 01:05)
Hot Pursuit - Zydus... - <p>Zydus Lifesciences Ltd is u...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2026 Mar | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 11,486.40 | 15,117.80 | 10,817.70 | 8,732.60 | 7,835.00 | 7,780.00 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 11,486.40 | 15,117.80 | 10,817.70 | 8,732.60 | 7,835.00 | 7,780.00 |
| Other Income | 1,667.50 | 696.20 | 1,084.80 | 548.40 | 178.70 | 89.30 |
| Stock Adjustments | 151.60 | 121.10 | 131.70 | -105.10 | 46.90 | 148.30 |
| Total Income | 13,305.50 | 15,935.10 | 12,034.20 | 9,175.90 | 8,060.60 | 8,017.60 |
| EXPENDITURE : | ||||||
| Raw Materials | 3,728.40 | 3,138.00 | 3,284.60 | 3,066.20 | 2,917.10 | 2,499.70 |
| Power and Fuel Cost | 305.60 | 286.20 | 298.20 | 278.60 | 245.20 | 193.20 |
| Employee Cost | 1,966.20 | 1,762.20 | 1,507.50 | 1,321.90 | 1,204.90 | 1,147.30 |
| Other Manufacturing Expenses | 486.70 | 439.70 | 347.20 | 332.50 | 381.10 | 363.40 |
| Selling and Administration Expenses | 1,805.40 | 1,629.30 | 1,016.80 | 1,040.80 | 956.50 | 1,009.10 |
| Miscellaneous Expenses | -412.80 | 247.20 | 445.00 | 336.90 | 578.30 | 594.40 |
| Employee Benefit Expenses | 1,966.20 | 1,762.20 | 1,507.50 | 1,321.90 | 1,204.90 | 1,147.30 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 7,879.50 | 7,502.60 | 6,899.30 | 6,376.90 | 6,283.10 | 5,807.10 |
| Operating Profit | 5,426.00 | 8,432.50 | 5,134.90 | 2,799.00 | 1,777.50 | 2,210.50 |
| Interest | 482.90 | 463.90 | 390.70 | 278.20 | 134.90 | 70.90 |
| Gross Profit | 4,943.10 | 7,968.60 | 4,744.20 | 2,520.80 | 1,642.60 | 2,139.60 |
| Depreciation | 561.20 | 523.90 | 504.40 | 488.60 | 478.70 | 451.10 |
| Profit Before Tax | 4,381.90 | 7,444.70 | 4,239.80 | 2,032.20 | 1,163.90 | 1,688.50 |
| Current Tax | 899.80 | 1,582.50 | 934.30 | 461.80 | 260.20 | 303.30 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -77.70 | 87.30 | -136.00 | 41.20 | 45.80 | -91.00 |
| Reported Net Profit | 3,559.80 | 5,774.90 | 3,441.50 | 1,529.20 | 857.90 | 1,476.20 |
| Extraordinary Items | -131.38 | 42.40 | 6.10 | -92.27 | -237.64 | -156.95 |
| Adjusted Net Profit | 3,691.18 | 5,732.50 | 3,435.40 | 1,621.47 | 1,095.54 | 1,633.15 |
| Adjustment below Net Profit | -10.10 | -26.40 | -54.00 | 1.80 | -6.90 | -15.30 |
| P & L Balance brought forward | 18,794.20 | 13,347.60 | 10,567.40 | 9,289.40 | 8,796.90 | 7,336.00 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 1,106.90 | 301.90 | 607.30 | 253.00 | 358.50 | 0.00 |
| P & L Balance carried down | 21,237.00 | 18,794.20 | 13,347.60 | 10,567.40 | 9,289.40 | 8,796.90 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 100.00 | 1,100.00 | 300.00 | 600.00 | 250.00 | 350.00 |
| Dividend Per Share(Rs) | 1.00 | 11.00 | 3.00 | 6.00 | 2.50 | 3.50 |
| Earnings Per Share-Unit Curr | 35.39 | 57.40 | 34.21 | 15.11 | 8.38 | 14.42 |
| Earnings Per Share(Adj)-Unit Curr | 35.39 | 57.40 | 34.21 | 15.11 | 8.38 | 14.42 |
| Book Value | 235.31 | 210.64 | 156.23 | 134.78 | 129.30 | 124.46 |
| Book Value(Adj)-Unit Curr | 235.31 | 210.64 | 156.23 | 134.78 | 129.30 | 124.46 |
